St. Johns Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$778K Buy
4,191
+305
+8% +$56.6K 0.36% 67
2025
Q1
$814K Sell
3,886
-107
-3% -$22.4K 0.4% 63
2024
Q4
$710K Sell
3,993
-82
-2% -$14.6K 0.33% 68
2024
Q3
$805K Buy
4,075
+40
+1% +$7.9K 0.38% 69
2024
Q2
$692K Buy
4,035
+27
+0.7% +$4.63K 0.33% 71
2024
Q1
$730K Buy
4,008
+624
+18% +$114K 0.35% 71
2023
Q4
$524K Sell
3,384
-104
-3% -$16.1K 0.27% 73
2023
Q3
$520K Buy
3,488
+15
+0.4% +$2.24K 0.3% 70
2023
Q2
$468K Sell
3,473
-1,671
-32% -$225K 0.25% 77
2023
Q1
$820K Sell
5,144
-2,206
-30% -$352K 0.48% 59
2022
Q4
$1.19M Sell
7,350
-116
-2% -$18.7K 0.71% 48
2022
Q3
$1M Buy
7,466
+287
+4% +$38.5K 0.66% 47
2022
Q2
$1.1M Sell
7,179
-143
-2% -$21.9K 0.7% 46
2022
Q1
$1.19M Sell
7,322
-162
-2% -$26.3K 0.63% 52
2021
Q4
$1.01M Sell
7,484
-95
-1% -$12.9K 0.52% 53
2021
Q3
$818K Buy
7,579
+330
+5% +$35.6K 0.45% 58
2021
Q2
$817K Buy
7,249
+74
+1% +$8.34K 0.44% 59
2021
Q1
$776K Buy
7,175
+121
+2% +$13.1K 0.45% 58
2020
Q4
$756K Sell
7,054
-181
-3% -$19.4K 0.47% 57
2020
Q3
$634K Buy
7,235
+451
+7% +$39.5K 0.43% 56
2020
Q2
$666K Buy
6,784
+281
+4% +$27.6K 0.49% 54
2020
Q1
$495K Buy
6,503
+557
+9% +$42.4K 0.44% 59
2019
Q4
$526K Sell
5,946
-280
-4% -$24.8K 0.37% 67
2019
Q3
$471K Sell
6,226
-130
-2% -$9.84K 0.35% 68
2019
Q2
$462K Sell
6,356
-195
-3% -$14.2K 0.34% 70
2019
Q1
$528K Buy
6,551
+790
+14% +$63.7K 0.41% 67
2018
Q4
$531K Buy
5,761
+559
+11% +$51.5K 0.47% 65
2018
Q3
$492K Buy
5,202
+275
+6% +$26K 0.37% 69
2018
Q2
$456K Buy
4,927
+4,887
+12,218% +$452K 0.34% 71
2018
Q1
$4K Hold
40
﹤0.01% 156
2017
Q4
$4K Hold
40
﹤0.01% 135
2017
Q3
$4K Hold
40
﹤0.01% 162
2017
Q2
$3K Hold
40
﹤0.01% 149
2017
Q1
$3K Hold
40
﹤0.01% 147
2016
Q4
$3K Hold
40
﹤0.01% 150
2016
Q3
$3K Hold
40
﹤0.01% 136
2016
Q2
$2K Hold
40
﹤0.01% 144
2016
Q1
$2K Buy
+40
New +$2K ﹤0.01% 141